{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:07:48Z","timestamp":1793120868884,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.gore.2025.101944","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:48:26Z","timestamp":1756946906000},"page":"101944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Management of significant pleural effusion at ovarian cancer diagnosis: Outcomes of triage to neoadjuvant chemotherapy without thoracic assessment"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-8626","authenticated-orcid":false,"given":"Stuart A.","family":"Ostby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ainio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conway","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly H.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Cliby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanika","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Langstraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2025.101944_b0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2005.08.027","article-title":"Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0010","doi-asserted-by":"crossref","unstructured":"G.D. Aletti, S.C. Dowdy, K.C. Podratz, W.A. Cliby, Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer., Am J Obstet Gynecol 197 (2007) 676.e1\u20137. DOI: 10.1016\/j.ajog.2007.10.495.","DOI":"10.1016\/j.ajog.2007.10.495"},{"key":"10.1016\/j.gore.2025.101944_b0015","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2014.60.5212","article-title":"Chemotherapy response score: Development and validation of a system to quantify histopathologic response to neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma","volume":"33","author":"B\u00f6hm","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0020","article-title":"Abstract #42: Real-world outcomes of neoadjuvant chemotherapy for ovarian cancer: what happens to patients who never undergo surgery?","volume":"57","author":"Bruce","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.gore.2025.101944_b0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2004.04.027","article-title":"The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/IGC.0000000000000680","article-title":"Role of video-assisted thoracoscopy in advanced ovarian cancer: a literature review","volume":"26","author":"Di Guilmi","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2025.101944_b0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2009.09.047","article-title":"Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients","volume":"116","author":"Diaz","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1200\/JCO-24-02589","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: ASCO guideline update","volume":"43","author":"Gaillard","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2017.05.023","article-title":"Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence","volume":"146","author":"Jamieson","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2022.12.023","article-title":"Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: going to the next level \u2013 a Memorial Sloan Kettering Cancer Center study","volume":"170","author":"Kahn","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40644-019-0215-7","article-title":"Behavior of FDG-avid supradiaphragmatic lymph nodes in PET\/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study","volume":"19","author":"Laasik","year":"2019","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.gore.2025.101944_b0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/ijgc-2019-000981","article-title":"Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis","volume":"30","author":"Larish","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2025.101944_b0065","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1186\/s12885-018-5067-1","article-title":"Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET\/CT in advanced epithelial ovarian cancer","volume":"18","author":"Lee","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gore.2025.101944_b0070","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ijgc-2018-000073","article-title":"Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study","volume":"29","author":"Lopes","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2025.101944_b0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2017.10.024","article-title":"Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival","volume":"148","author":"Mert","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ygyno.2020.03.024","article-title":"Less guessing, more evidence in identifying patients least fit for cytoreductive surgery in advanced ovarian cancer: a triage algorithm to individualize surgical management","volume":"157","author":"Narasimhulu","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0085","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ygyno.2020.12.026","article-title":"Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy","volume":"160","author":"Narasimhulu","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0090","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v035.b01","article-title":"ggplot2: elegant graphics for data analysis","volume":"35","author":"Valero-Mora","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.gore.2025.101944_b0095","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S1470-2045(18)30566-7","article-title":"EORTC, MRC CHORUS study investigators, Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials","volume":"19","author":"Vergote","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.gore.2025.101944_b0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Gynecologic Oncology Group, Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"26","author":"Winter","year":"2008","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925001699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925001699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:09:19Z","timestamp":1761185359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578925001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"alternative-id":["S2352578925001699"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101944","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of significant pleural effusion at ovarian cancer diagnosis: Outcomes of triage to neoadjuvant chemotherapy without thoracic assessment","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101944"}}